Pre-Diabetes/Impaired Glucose Tolerance Ongoing Global Clinical Trials Analysis and Outlook
Pre-Diabetes/Impaired Glucose Tolerance ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Pre-Diabetes/Impaired Glucose Tolerance disease clinical trials. The research work analyzes the ongoing Pre-Diabetes/Impaired Glucose Tolerance clinical trial trends across countries and companies.
The report focuses on drugs and therapies being evaluated for Pre-Diabetes/Impaired Glucose Tolerance treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.
Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Pre-Diabetes/Impaired Glucose Tolerance clinical trials.
Scope of the Report-
The report focuses on drugs and therapies being evaluated for Pre-Diabetes/Impaired Glucose Tolerance treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.
Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Pre-Diabetes/Impaired Glucose Tolerance clinical trials.
Scope of the Report-
- Ongoing Pre-Diabetes/Impaired Glucose Tolerance clinical trials across regions
- Trial information by Phase and Subjects recruited
- Trial information by status, type, sponsor type
- Drugs used for treatment of Pre-Diabetes/Impaired Glucose Tolerance
- Both observational and interventional trials analyzed
- Leading companies and universities participating in Pre-Diabetes/Impaired Glucose Tolerance clinical trials
- Track competition and design competitive advantages
- Identify right partners to associate with for further research
- Evaluate potential opportunities available in further clinical trials of the disease
- Formulate business development strategies through success rates of clinical trials
- Identify quick markets for recruiting subjects based on trials count by each market
1 TABLE OF CONTENTS
1.1 List of Figures
1.2 List of Tables
2 KEY FINDINGS, 2018
2.1 Snapshot
2.2 Overview of Pre-Diabetes/Impaired Glucose Tolerance Trials
3 CLINICAL TRIALS TRENDS TO 2022
3.1 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials by Phase
3.2 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials by Type
3.3 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials by Recruitment Status
4 COUNTRY LEVEL ANALYSIS
4.1 Region wise Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials
4.2 Top 10 Countries conducting Pre-Diabetes/Impaired Glucose Tolerance Trials
4.3 Trials in Emerging and Developing Economies
5 COMPANY LEVEL ANALYSIS
5.1 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials by Sponsor Type
5.2 Pre-Diabetes/Impaired Glucose Tolerance Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors
6 ENROLMENT TRENDS TO 2022
6.1 Subjects Recruited for Pre-Diabetes/Impaired Glucose Tolerance Trials by year
6.2 Subjects Recruited for Pre-Diabetes/Impaired Glucose Tolerance Trials by Phase
6.3 Subjects Recruited for Pre-Diabetes/Impaired Glucose Tolerance Trials by Trial Type
6.4 Subjects Recruited for Pre-Diabetes/Impaired Glucose Tolerance Trials by Recruitment Status
7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS
7.1 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials- Phase
7.2 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials- Phase
7.3 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials- Phase
7.4 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials- Phase
8 APPENDIX
8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology
1.1 List of Figures
1.2 List of Tables
2 KEY FINDINGS, 2018
2.1 Snapshot
2.2 Overview of Pre-Diabetes/Impaired Glucose Tolerance Trials
3 CLINICAL TRIALS TRENDS TO 2022
3.1 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials by Phase
3.2 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials by Type
3.3 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials by Recruitment Status
4 COUNTRY LEVEL ANALYSIS
4.1 Region wise Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials
4.2 Top 10 Countries conducting Pre-Diabetes/Impaired Glucose Tolerance Trials
4.3 Trials in Emerging and Developing Economies
5 COMPANY LEVEL ANALYSIS
5.1 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials by Sponsor Type
5.2 Pre-Diabetes/Impaired Glucose Tolerance Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors
6 ENROLMENT TRENDS TO 2022
6.1 Subjects Recruited for Pre-Diabetes/Impaired Glucose Tolerance Trials by year
6.2 Subjects Recruited for Pre-Diabetes/Impaired Glucose Tolerance Trials by Phase
6.3 Subjects Recruited for Pre-Diabetes/Impaired Glucose Tolerance Trials by Trial Type
6.4 Subjects Recruited for Pre-Diabetes/Impaired Glucose Tolerance Trials by Recruitment Status
7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS
7.1 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials- Phase
7.2 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials- Phase
7.3 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials- Phase
7.4 Ongoing Pre-Diabetes/Impaired Glucose Tolerance Trials- Phase
8 APPENDIX
8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology
LIST OF FIGURES
Figure 1: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Country
Figure 2: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Phase of Development, 2018
Figure 3: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Status, 2018
Figure 4: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Type, 2018
Figure 5: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials Split by Region, 2000-2018
Figure 6: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Type of Economy, 2018
Figure 7: Pre-Diabetes/Impaired Glucose Tolerance- Enrolment by Phase, 2018
Figure 8: Pre-Diabetes/Impaired Glucose Tolerance- Enrolment by Trial Type, 2018
Figure 9: Pre-Diabetes/Impaired Glucose Tolerance- Enrolment by Recruitment Status, 2018
Figure 10: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Sponsor Type, 2018
Figure 11: Pre-Diabetes/Impaired Glucose Tolerance- Enrolment by Type of Sponsors
Figure 12: Pre-Diabetes/Impaired Glucose Tolerance- Enrolment by Leading Sponsors
Figure 1: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Country
Figure 2: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Phase of Development, 2018
Figure 3: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Status, 2018
Figure 4: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Type, 2018
Figure 5: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials Split by Region, 2000-2018
Figure 6: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Type of Economy, 2018
Figure 7: Pre-Diabetes/Impaired Glucose Tolerance- Enrolment by Phase, 2018
Figure 8: Pre-Diabetes/Impaired Glucose Tolerance- Enrolment by Trial Type, 2018
Figure 9: Pre-Diabetes/Impaired Glucose Tolerance- Enrolment by Recruitment Status, 2018
Figure 10: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Sponsor Type, 2018
Figure 11: Pre-Diabetes/Impaired Glucose Tolerance- Enrolment by Type of Sponsors
Figure 12: Pre-Diabetes/Impaired Glucose Tolerance- Enrolment by Leading Sponsors
LIST OF TABLES
Table 1: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Sponsor Type, 2018
Table 2: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Economy Type, 2018
Table 3: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Region, 2018
Table 4: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Pre-Diabetes/Impaired Glucose Tolerance- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Pre-Diabetes/Impaired Glucose Tolerance- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Pre-Diabetes/Impaired Glucose Tolerance- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Pre-Diabetes/Impaired Glucose Tolerance- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 1: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Sponsor Type, 2018
Table 2: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Economy Type, 2018
Table 3: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials by Region, 2018
Table 4: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Pre-Diabetes/Impaired Glucose Tolerance- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Pre-Diabetes/Impaired Glucose Tolerance- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Pre-Diabetes/Impaired Glucose Tolerance- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Pre-Diabetes/Impaired Glucose Tolerance- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Pre-Diabetes/Impaired Glucose Tolerance- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
